pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,423 catalysts · 3,368 8k filing · 1,080 grant · 1,000 device adverse event · 579 earnings · 519 approval · 408 device 510k

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-17: 19 catalysts2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-03-04×clear all
type
  • 8k filing3,368
  • grant1,080
  • device adverse event1,000
  • earnings579
  • approval519
  • device 510k408
  • device pma236
  • phase 2 completion172
  • drug shortage133
  • recall121
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Mar 30, 2026

    50
    ›Mar 30, 2026approval141d agoBUPROPION HYDROCHLORIDE — FDA approvalBUPROPION HYDROCHLORIDE

    Sponsor: YICHANG HUMANWELL. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →BUPROPION HYDROCHLORIDE →fda approvals ↗
    ›Mar 30, 2026approval141d agoBENZONATATE — FDA approvalBENZONATATE

    Sponsor: MARKSANS PHARMA. Form: CAPSULE. Route: ORAL

    full page →BENZONATATE →fda approvals ↗
    ›Mar 30, 2026approval141d agoZYNYZ (RETIFANLIMAB-DLWR) — FDA approvalretifanlimab

    Sponsor: INCYTE CORP. Form: INJECTABLE. Route: INTRAVENOUS

    full page →retifanlimab →fda approvals ↗
    ›Mar 30, 2026approval141d agoEPINEPHRINE — FDA approvaladrenaline

    Sponsor: BAXTER HLTHCARE CORP. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS

    full page →adrenaline →fda approvals ↗
    ›Mar 30, 2026approval141d agoLIRAGLUTIDE — FDA approvalSaxenda

    Sponsor: FRESENIUS KABI USA. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →Saxenda →fda approvals ↗
    ›Mar 30, 2026approval141d agoFOCINVEZ (FOSAPREPITANT DIMEGLUMINE) — FDA approvalAthenex Inc (Inactive)

    Sponsor: STERISCIENCE. Form: SOLUTION. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Mar 30, 2026approval141d agoPREGABALIN — FDA approvalPREGABALIN

    Sponsor: ESKAYEF. Form: CAPSULE. Route: ORAL

    full page →PREGABALIN →fda approvals ↗
    ›Mar 30, 2026approval141d agoVALPROIC ACID — FDA approvalCereno Scientific AB

    Sponsor: SUN PHARM INDS LTD. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 30, 2026approval141d agoGLIPIZIDE — FDA approvalGreenstone LLC

    Sponsor: WATSON LABS TEVA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 30, 2026approval141d agoBYOOVIZ (RANIBIZUMAB-NUNA) — FDA approvalBYOOVIZ

    Sponsor: SAMSUNG BIOEPIS CO LTD. Form: INJECTABLE. Route: INJECTION

    full page →BYOOVIZ →fda approvals ↗
    ›Mar 30, 2026device 510k141d agoSpectrum Spine — Spectrum Spine Cervical Cage System; Spectrum Spine Lumbar Cage System (510k cleared)

    Product code: ODP. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 30, 2026device 510k141d agoBaebies, Inc. — FINDER Flu A&B/SARS-CoV-2 Test (510k cleared)

    Product code: QOF. Advisory committee: Microbiology. Type: Dual Track

    full page →fda device 510k ↗
    ›Mar 30, 2026device 510k141d agoBloomden Bioceramics (HuNan) Co., Ltd. — Bloomden Dental Zirconia Blank & Dental Zirconia Pre-Shaded Blank (510k cleared)

    Product code: EIH. Advisory committee: Dental. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 30, 2026device 510k141d agoArthroCare Corporation — FLOW FLEXTEND Wand (72290039) (510k cleared)

    Product code: GEI. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 30, 2026device 510k141d agoPhilips Medizin Systeme Böblingen GmbH — IntelliVue Measurement Rack 6000 (867317) (510k cleared)

    Advisory committee: Unknown. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 30, 2026device 510k141d agoImplantcast GmbH — implantcast Packaging System Update (510k cleared)

    Product code: LZO. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 30, 2026device 510k141d agoCenters for Disease Control and Prevention — Francisella tularensis Real-time PCR Assay (510k cleared)Hubei Provincial Center for Disease Control and Prevention

    Product code: SGA. Advisory committee: Immunology. Type: Special

    full page →fda device 510k ↗
    ›Mar 30, 2026device 510k141d agoViTAA Medical Solutions, Inc. — AiORTA - Plan v2.0 (510k cleared)

    Product code: QIH. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 30, 2026device 510k141d agoMayer Laboratories — Sagami Original 002 Polyurethane Male Condom (510k cleared)

    Product code: MOL. Advisory committee: Obstetrics/Gynecology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 30, 2026device 510k141d agoAvatar Medical — Avatar Medical Vision (510k cleared)

    Product code: LLZ. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 30, 2026device pma141d agoBiotronik, Inc. — Amvia-Solvia Pulse Generators Scan Duration Extension (PMA supplement)

    Supplement type: Real-Time Process. Product code: DXY. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Mar 30, 2026device pma141d agoKaneka Pharma America Corp. — LIPOSORBER® LA-15 System (PMA supplement)

    Supplement type: Real-Time Process. Product code: MMY. Advisory committee: GU. Decision: APPR

    full page →fda device pma ↗
    ›Mar 30, 2026device pma141d agoOrganox Limited — OrganOx metra® System (PMA supplement)

    Supplement type: Normal 180 Day Track. Product code: QQK. Advisory committee: GU. Decision: APPR

    full page →fda device pma ↗
    ›Mar 30, 2026grant141d agoUNIVERSITY OF COLORADO DENVER — Kir2.1 channel dysfunction underlies neurovascular coupling impairment in autismUniversity of Colorado Denver

    HL grant. $38,224. PI: Phinea Z Romero

    full page →nih reporter ↗
    ›Mar 30, 2026grant141d agoWEILL MEDICAL COLL OF CORNELL UNIV — Mechanisms of HBx Recognition and Epigenetic Regulation of HBV cccDNA

    AI grant. $50,114. PI: Tracy Biaco

    full page →nih reporter ↗
    ›Mar 31, 2026approval140d agoDEPAKOTE (DIVALPROEX SODIUM) — FDA approvaldivalproex sodium DR

    Sponsor: ABBVIE. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL

    full page →divalproex sodium DR →fda approvals ↗
    ›Mar 31, 2026approval140d agoSTAVZOR (VALPROIC ACID) — FDA approvalVALPROIC ACID

    Sponsor: BIONPHARMA. Form: CAPSULE, DELAYED RELEASE. Route: ORAL

    full page →VALPROIC ACID →fda approvals ↗
    ›Mar 31, 2026approval140d agoVALPROATE SODIUM — FDA approvalSagent Pharmaceuticals Inc

    Sponsor: HIKMA FARMACEUTICA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 31, 2026approval140d agoVALPROATE SODIUM — FDA approvalSagent Pharmaceuticals Inc

    Sponsor: HIKMA FARMACEUTICA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 31, 2026approval140d agoVALPROATE SODIUM — FDA approvalSagent Pharmaceuticals Inc

    Sponsor: HIKMA FARMACEUTICA. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 31, 2026approval140d agoVALPROIC ACID — FDA approvalVALPROIC ACID

    Sponsor: LANNETT CO INC. Form: SYRUP. Route: ORAL

    full page →VALPROIC ACID →fda approvals ↗
    ›Mar 31, 2026approval140d agoMETHYLENE BLUE — FDA approvalMETHYLENE BLUE

    Sponsor: ZYDUS LIFESCIENCES. Form: SOLUTION. Route: INTRAVENOUS

    full page →METHYLENE BLUE →fda approvals ↗
    ›Mar 31, 2026approval140d agoDEPAKOTE ER (DIVALPROEX SODIUM) — FDA approvaldivalproex sodium DR

    Sponsor: ABBVIE. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →divalproex sodium DR →fda approvals ↗
    ›Mar 31, 2026approval140d agoDEPAKOTE (DIVALPROEX SODIUM) — FDA approvaldivalproex sodium DR

    Sponsor: ABBVIE. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →divalproex sodium DR →fda approvals ↗
    ›Mar 31, 2026approval140d agoVALPROATE SODIUM — FDA approvalVALPROATE SODIUM

    Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INJECTION

    full page →VALPROATE SODIUM →fda approvals ↗
    ›Mar 31, 2026approval140d agoVALPROATE SODIUM — FDA approvalVALPROATE SODIUM

    Sponsor: SAGENT. Form: INJECTABLE. Route: INJECTION

    full page →VALPROATE SODIUM →fda approvals ↗
    ›Mar 31, 2026approval140d agoVALPROIC ACID — FDA approvalVALPROIC ACID

    Sponsor: HIKMA. Form: SYRUP. Route: ORAL

    full page →VALPROIC ACID →fda approvals ↗
    ›Mar 31, 2026approval140d agoVALPROIC ACID — FDA approvalCereno Scientific AB

    Sponsor: HIBROW HLTHCARE. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 31, 2026approval140d agoVALPROIC ACID — FDA approvalCereno Scientific AB

    Sponsor: PHARMOBEDIENT CNSLTG. Form: SYRUP. Route: ORAL

    full page →fda approvals ↗
    ›Mar 31, 2026approval140d agoVALPROIC ACID — FDA approvalANI PHARMACEUTICALS INC

    Sponsor: ANI PHARMS. Form: SYRUP. Route: ORAL

    full page →fda approvals ↗
    ›Mar 31, 2026approval140d agoINBRIJA (LEVODOPA) — FDA approvallevodopa

    Sponsor: MERZ. Form: POWDER. Route: INHALATION

    full page →levodopa →fda approvals ↗
    ›Mar 31, 2026approval140d agoOLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalSciegen Pharmaceuticals Inc

    Sponsor: SCIEGEN PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 31, 2026approval140d agoVALPROATE SODIUM — FDA approvalSagent Pharmaceuticals Inc

    Sponsor: PHARMOBEDIENT. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 31, 2026approval140d agoVALPROIC ACID — FDA approvalCereno Scientific AB

    Sponsor: CHARTWELL RX. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 31, 2026approval140d agoVALPROIC ACID — FDA approvalCereno Scientific AB

    Sponsor: CHARTWELL RX. Form: SYRUP. Route: ORAL

    full page →fda approvals ↗
    ›Mar 31, 2026approval140d agoMESALAMINE — FDA approvalTakeda Pharmaceuticals USA Inc

    Sponsor: KLM LABS PVT. Form: ENEMA. Route: RECTAL

    full page →fda approvals ↗
    ›Mar 31, 2026device 510k140d agoZhenjiang Assure Medical Equipment Co., Ltd. — K5 wheelchair (16” with swing-away footrest 18” with swing-away footrest 20” with swing-away footrest 16” with elevated foot rest(ELR) 18” with elevated foot rest(ELR) 20” with elevated foot rest(ELR)) (510k cleared)

    Product code: IOR. Advisory committee: Physical Medicine. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 31, 2026device 510k140d agoMediott, Inc. — RW-1 (510k cleared)

    Product code: LLZ. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 31, 2026device 510k140d agoSanhe Meditech Co., Ltd. — Nd: YAG Laser Therapy Systems (510k cleared)

    Product code: GEX. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 31, 2026device 510k140d agoTianjin Huahong Technology Co., Ltd. — Safety lancet (XXXVII) (510k cleared)

    Product code: FMK. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ← prev
    page 23 of 149
    next →
    $INCY120.16-0.30%
    $ANIP76.52-0.03%
    $ABBV249.42-0.06%
    $ABBV249.42-0.06%
    $ABBV249.42-0.06%